Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said he wouldn’t be surprised if the Johnson & Johnson vaccine candidate got emergency use authorization from the US Food and Drug Administration within the next two weeks.
“The J&J data right now, that we discussed last week, is being reviewed with the FDA right now, so we could see literally within a week or so that they wind up getting the kind of emergency use authorization,” he told NBC’s Savannah Guthrie Wednesday. “I don’t want to get ahead of the FDA, but I would not be surprised, Savannah, if this happens within the next week or two.”
Johnson & Johnson will be the third company to seek emergency use authorization from the FDA for a coronavirus vaccine.
For the Pfizer vaccine, it took a little over three weeks from the time the company submitted its data to an EUA.
For the Moderna vaccine, it took a little more than two weeks.
